Oncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future Perspectives
The concept of oncolytic virus (OV)-mediated cancer therapy has been shifted from an operational virotherapy paradigm to an immunotherapy. OVs often induce immunogenic cell death (ICD) of cancer cells, and they may interact directly with immune cells as well to prime antitumor immunity. We and other...
Main Authors: | Zong Sheng Guo, Zuqiang Liu, Stacy Kowalsky, Mathilde Feist, Pawel Kalinski, Binfeng Lu, Walter J. Storkus, David L. Bartlett |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-05-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fimmu.2017.00555/full |
Similar Items
-
Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity
by: Zong Sheng eGuo, et al.
Published: (2014-04-01) -
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
by: Zong Sheng Guo, et al.
Published: (2019-01-01) -
Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy
by: Zuqiang Liu, et al.
Published: (2017-03-01) -
Editorial: Oncolytic Viruses—Genetically Engineering the Future of Cancer Therapy
by: Benjamin Gesundheit, et al.
Published: (2017-11-01) -
In Vivo Priming of Peritoneal Tumor-Reactive Lymphocytes With a Potent Oncolytic Virus for Adoptive Cell Therapy
by: Esther Giehl, et al.
Published: (2021-02-01)